SOURCE: Industrial Info Resources

Industrial Info Resources

February 15, 2011 05:10 ET

Half a Billion of Prevention Is Worth the Cure as Pharma-Biotech Industry Protects Manufacturing Investment With Scheduled MRO, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - February 15, 2011) -  Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Admittedly, it is not easy in today's pharmaceutical-biotech marketplace to convince a board of directors to spend hundreds of millions of dollars to build a grassroot manufacturing plant. On the other hand, millions are essential to protect the sizeable investment already in place. The last thing any drugs, medical devices or toiletries manufacturer needs is equipment failure or malfunction within the production process. Just ask Johnson & Johnson (NYSE:JNJ) (New Brunkswick, New Jersey) about the entire recall debacle from which they have yet to recover.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to or visit us at

Follow us on: Facebook - Twitter - LinkedIn - Vimeo